Novartis’ Spin-off of Sandoz’s Generic and Biosimilar Drugs Business

Bär & Karrer acted as Swiss legal and tax advisor to Novartis and Sandoz. Cravath represented Novartis as U.S. tax counsel.Novartis has completed the spin-off of…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Marco Zingaro

This content is for Standard 1 Year members only.
Login Join Now